These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 548652)

  • 1. Abrogation of the proliferation of human leukemia cells in nude mice by a xenoantiserum.
    Latif ZA; Lozzio BB; Lozzio CB; Herberman RB; Wust CJ
    Leuk Res; 1979; 3(6):371-8. PubMed ID: 548652
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytotoxic activity in mouse tumors by lymphocytes with anti-streptococcal specific antibodies].
    Fujioka T; Tanji S; Koike H; Kumagai K; Aoki H; Kubo T; Ohhori T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1243-7. PubMed ID: 3068321
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.
    Sanfilippo F; Kao KJ; Pizzo SV; Collins JJ
    J Natl Cancer Inst; 1980 Mar; 64(3):547-53. PubMed ID: 6928240
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic and cytokinetic parameters of BCG-induced growth control of a murine leukemia.
    Olsson L
    Recent Results Cancer Res; 1977; (62):28-35. PubMed ID: 601336
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of immunotoxins containing ricin A or B chains to kill neoplastic B cells.
    Vitetta ES; Uhr JW
    Ann N Y Acad Sci; 1985; 446():228-36. PubMed ID: 3860153
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of PSK on cytotoxicity against sarcoma-180 in tumor-bearing mice.
    Oguchi Y; Ando T; Matsunaga K; Fujii T; Yoshikumi C; Nomoto K
    Anticancer Res; 1987; 7(4B):681-4. PubMed ID: 3499859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral immunity to leukemia cells in BCG-induced growth control of a murine leukemia.
    Olsson L; Florentin I; Kiger N; Mathé G
    J Natl Cancer Inst; 1977 Oct; 59(4):1297-306. PubMed ID: 904001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen.
    Bernstein ID; Tam MR; Nowinski RC
    Science; 1980 Jan; 207(4426):68-71. PubMed ID: 6965328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunotherapeutic effects in tumor-bearing mice of Ly-6 monoclonal antibodies.
    Lu L; Palladino MA; DeLeo AB
    J Immunol; 1989 Jan; 142(2):719-25. PubMed ID: 2783443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymocytolytic autoantibodies elicited by immunization of mice with chemically-induced sarcoma and leukemia cells.
    Merino F
    Acta Cient Venez; 1982; 33(5):402-5. PubMed ID: 6985343
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined radiotherapy and Corynebacterium parvum treatment of rat tumors with different immunogenicity.
    Moroson H; Stowe S; Rotman M; Schechter M
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):649-55. PubMed ID: 711536
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of drug-antibody conjugates in the treatment of human myelosarcomas transplanted in nude mice.
    Latif ZA; Lozzio BB; Wust CJ; Krauss S; Aggio MC; Lozzio CB
    Cancer; 1980 Mar; 45(6):1326-33. PubMed ID: 6928397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducible metastatic growth of K-562 human myelogenous leukemia cells in nude mice.
    Lozzio BB; Machado EA; Lair SV; Lozzio CB
    J Natl Cancer Inst; 1979 Aug; 63(2):295-9. PubMed ID: 287825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706
    [No Abstract]   [Full Text] [Related]  

  • 15. A streptococcal preparation (OK-432) enhances monoclonal antibody NCC-ST-421 cytotoxicity against human colon cancer.
    Kawano Y; Watanabe M; Kubota T; Nishibori H; Kurihara N; Teramoto T; Kitajima M
    Anticancer Res; 1997; 17(4A):2449-53. PubMed ID: 9252661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of tumor cell extracts in immunotherapy of murine EL-4 leukemia.
    Cantrell JL; McLaughlin CA; Ribi E
    Cancer Res; 1979 Apr; 39(4):1159-67. PubMed ID: 421199
    [No Abstract]   [Full Text] [Related]  

  • 17. A new model for leukemia-lymphoma metastasis: differential growth and rejection of murine lymphoid-leukemia cell lines in the bone marrow.
    Kamenov B; Kieran MW; Leigh JB; Greenberg AH; Longenecker BM
    Symp Fundam Cancer Res; 1983; 36():245-64. PubMed ID: 6679093
    [No Abstract]   [Full Text] [Related]  

  • 18. Serochemotherapy against a Moloney virus-induced leukemia.
    Pearson GR; Redmon LW; Pearson JW
    Cancer Res; 1973 Aug; 33(8):1854-7. PubMed ID: 4578564
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of hapten plus antihapten-tumor serum treatment on established rat fibrosarcoma.
    Arai K; Spencer JS; Sohn M; Wallace HW
    Cancer Res; 1979 Jan; 39(1):6-16. PubMed ID: 310708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.